# Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

> **NCT00335660** · PHASE2 · TERMINATED · sponsor: **Avera Pharmaceuticals** · enrollment: 62 (estimated)

## Conditions studied

- Overactive Bladder Syndrome

## Interventions

- **DRUG:** AV608

## Key facts

- **NCT ID:** NCT00335660
- **Lead sponsor:** Avera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2007-06
- **Final completion:** 2007-09
- **Target enrollment:** 62 (ESTIMATED)
- **Why stopped:** Animal Safety Data
- **Last updated:** 2008-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335660, "Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00335660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*